
Working Group Releases Strategy to Ensure Import Safety
The US Food and Drug Administration’s Interagency Working Group on Import Safety released a Strategic Framework based on a cost-effective, risk-based approach for ensuring the safety of products exported to the United States.
Washington, DC (Sept. 10)-The
The Strategic Framework follows several months of scandals involving contaminated products manufactured in China. The scandals prompted the US government to send a fact-finding team to China to address concerns about food and drug safety.
The Working Group aims to achieve continuous improvement in import safety by using the following six “building blocks”:
- Advance a Common Vision
- Increase Accountability, Enforcement, and Deterrence
- Focus on Risk Over the Life Cycle of an Imported Product
- Build Interoperable Systems
- Foster a Culture of Collaboration
- Promote Technological Innovation and New Science.
The building blocks recommend changes to the oversight process, including shared goals among federal agencies that promote import safety, better communication between parties in the global supply chain, and collaboration between government and industry.
The Framework says FDA has made 34 confidential arrangements with agencies in 17 countries to share approval, inspection, adverse-event, and emergency information about products manufactured in a partners’ territories. FDA currently has more than two such exchanges each day.
In a
President Bush established the Working Group by executive order on July 18, 2007. The Working Group is charged with developing better ways to work with importers, manufacturers, and other governments to ensure the safety of imported products.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





